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Objective To examine the associations of maternal and child
overweight status across multiple time-points with liver fat
content in the offspring during young adulthood.
Design Cohort study.
Setting ELEMENT Cohort in Mexico City.
Population Pregnant women with singleton births (n = 97).
Methods We quantified hepatic triglyceride content (liver fat
content) by proton magnetic resonance spectroscopy (1H
MRS) and conventional T2-weighted MRIs (3T scanner) in
97 young adults from the ELEMENT birth cohort in Mexico
City. Historical records of the cohort were used as a source
of pregnancy, and childhood and adolescence anthropometric
information, overweight and obesity (OWOB) were defined.
Adjusted structural equation models were run to identify the
association between OWOB in different life stages with liver
fat content (log-transformed) in young adulthood.
Main outcome Maternal OWOB at the time of delivery was
directly and indirectly associated with the liver fat content in the
offspring at young adulthood.
Results Seventeen percent of the participants were classified as having
NAFLD. We found a strong association of OWOB between all
periods assessed. Maternal OWOB at time of delivery (b = 1.97, 95%
CI 1.28–3.05), and OWOB status in the offspring at young adulthood
(b = 3.17, 95% CI 2.10–4.77) were directly associated with the liver
fat content in the offspring. Also, maternal OWOB was indirectly
associated with liver fat content through offspring OWOB status.
Conclusion We found that maternal OWOB status is related to fatty
liver content in the offspring as young adults, even after taking into
account OWOB status and lifestyle factors in the offspring.
Keywords Cohort, liver fat content, maternal overweight.
Tweetable abstract There was an association between pre-pregnancy
overweight and the development of NAFLD in adult offspring.
Please cite this paper as: Cantoral A, Montoya A, Luna-Villa L, Roldan-Valadez EA, Hernandez-Avila M, Kershenobich D, Perng W, Peterson KE, Hu H,
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Introduction
Non-alcoholic fatty liver disease (NAFLD), defined as hep-
atic fat infiltration involving more than 5% of the
hepatocytes in the absence of high alcohol intake and other
causes of liver pathology,1 is the most common cause of
chronic liver disease in western countries2 and may be a
precursor to other leading chronic diseases such as type 2




diabetes mellitus.3-6 Known as the ‘silent liver disease’,
most individuals with NAFLD are asymptomatic until pro-
gression to advanced stages of disease involving inflamma-
tion (non-alcoholic steatohepatitis [NASH]), fibrosis,
cirrhosis and ultimately, in some cases, hepatocellular carci-
noma.7
The worldwide prevalence of NAFLD is around 20%1
has more than doubled in young adults since the 1980s,8,9
particularly among obese individuals.10 In Mexico, the
national prevalence of NAFLD is unknown; however, a
2006 study of asymptomatic individuals from the general
population reported a 17% prevalence,11 with an expected
prevalence of up to 26% in adults based on current obesity
rates.12,13 Perhaps of more concern is that NAFLD is now
on the rise at younger ages,14 reflecting, in part, the child-
hood obesity pandemic and the relatively high intakes of
energy-dense processed foods and sugar-sweetened bever-
ages.15
Some cohort studies in developed nations have identified
early risk factors for NAFLD, including in utero exposure
to maternal obesity16 and childhood growth patterns.17-19
Less is known of these associations in developing countries
undergoing the nutrition transition,20 where rapid shifts in
diet and lifestyle may further compound the long-term
consequences of obesogenic early life exposures. Thus, the
goals of this study were to estimate liver fat content and
NAFLD prevalence, and to assess the independent, cumula-
tive and trans-generational effects of exposure to over-
weight/obesity (OWOB) across the life course from the in
utero period through young adulthood on liver fat content
in a sample of young adults in Mexico City, Mexico.
Methods
This study was conducted in a subsample of young adult
offspring from the first birth cohort of the Early Life Expo-
sure in Mexico to Environmental Toxicants (ELEMENT)
project. Details of the cohort are reported elsewhere.21 In
summary, between 1994 and 1995 a total of 631 mothers
were recruited at delivery, and their offspring have been
followed over time. Information from pregnancy (pre-preg-
nancy self-reported weight and parity), delivery (mother’s
weight, birthweight, offspring sex) and up through 4 years
post-partum (breastfeeding practices, weight, length/height)
were obtained from the historical records of the cohort.
From 2008 to 2010, a subsample of 206 participants (from
the original 631) participated in a research visit during
adolescence at approximately 14–16 years of age.22
In 2016, a young-adult visit (21–22 years of age) was
conducted.23 Of the 206 participants who attended the pre-
vious visit, 55 did not respond and 51 chose not to partici-
pate. Of the remaining 100, the present analysis included
97 participants with complete information key variables. At
the young-adult visit, participants were asked to participate
in the assessment of liver fat content following a 10-hour
fast. All subjects provided written informed consent. Partic-
ipants’ involvement in this study is described in
Appendix S1.
Outcome variable: quantification of liver fat in
young adulthood
To estimate the hepatic triglyceride content, we performed
proton magnetic resonance spectroscopy (1H MRS),24 with
calculation of the proton density fat fraction (PDFF).
PDFF, a standardised magnetic resonance (MR)-biased bio-
marker of steatosis, is defined as the fraction of mobile
protons (1H) derived from triglycerides relative to those
derived from water.25 A Philips Achieva 3.0 T MR-scanner
(Philips Healthcare, Best, the Netherlands) was used for
imaging. Conventional MR imaging was done prior to the
spectroscopy acquisition. The methodology to measure the
fat fraction using 1H MRS has been described by our
group previously.26 The protocol included plane localisers:
transversal T2w, Transversal T2w with fat saturation. A
board-certified radiologist (E.R.V.) and a biomedical engi-
neer who post-processed the information and gave the
results, were ‘blinded’ about the participant’s body mass
index (BMI) status.
Liver images were acquired with an 8-channel torso coil
during a breath-hold. This breath-hold was monitored with
a respiratory belt. Two 30 9 30 9 30 mm voxels were
selected within normal liver tissue in the right lobe of the
liver as described elsewhere,26 avoiding the edge of the liver
and major blood vessels. The resonances used for calcula-
tion of the triglycerides were water (peak at 4.7 ppm),
methylene (CH2 peak at 1.3 ppm) and methyl (CH3 peak
at 0.9 ppm). The fat fraction in each pixel then was calcu-
lated using 1H MRS as the ratio of the fat density to the
total (fat and water) density. A detailed description of the
imaging examination and post-processing analysis has been
described elsewhere.26–28
An example of the acquired images and spectra is
depicted in Figure S1. In the analysis, we assessed liver fat
content as a continuous variable (log-transformed) and as
a dichotomous NAFLD (yes/no) using a cut-off value of
5% hepatic fat fraction to define presence of NAFLD.29
Exposures variables: OWOB in mothers (pre-
pregnancy and delivery) and OWOB in offspring
(childhood, adolescence and young adulthood)
Maternal OWOB
The cohort’s historical records were used to obtain mater-
nal information including: self-reported pre-pregnancy
weight, weight and height measured at the end of preg-
nancy (using professional scales PAME, Puebla), which
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were used to calculate pre-pregnancy BMI and maternal
BMI at delivery. Parity information was categorised as first
pregnancy. Breastfeeding practices were recorded as total
months and categorised as never breastfeeding or breast-
feeding at least 1 month during the first year postpartum.
Maternal BMI was classified as normal weight (<25 kg/m2)
and OWOB (≥25 kg/m2) for pre-pregnancy and delivery.30
We did not include underweight (<18.5 kg/m2) as none of
the participants fell into this category.
Offspring OWOB at different periods
Anthropometric measures of the participants during the
preschool period were also captured (weight and stature,
using a calibrated beam scale, Model TD16 and infan-
tometer, SECA) every 6 months from birth to 4 years of
age. This information was used to estimate weight for
length/height Z-score according to the World Health
Organization (WHO) growth standard. We defined over-
weight status between 1 and 2 years of age as weight-for-
length Z-score (WLZ) >2 SD, and from 2 to 4 years as
weight-for-height Z-score (WHZ) >2SD, in at least one
time measure.31
In adolescence, trained personnel measured weight and
height using standard techniques. Weight was measured
using a digital scale (BAME 147 Mod 420; Catalogo
Medico, Mexico City, Mexico) and read to the nearest
0.1 kg. Standing height was evaluated using a calibrated
stadiometer (BAME Mod 420; Catalogo Medico) and read
to the nearest 0.5 cm. BMI was calculated as an age- and
sex-specific Z-score and classified as OWOB ≥1 SD of the
BMI Z-score.32
In adulthood, weight and height were measured using a
Tanita digital scale with a height rod (model WB-3000m).
Weight was recorded to the nearest 0.1 kg and height to
the nearest 0.5 cm. BMI was calculated and classified as
OWOB (for BMI ≥25 kg/m2). All the measurements were
done by trained personnel.
Covariates: socio-demographic and lifestyle
information in young adulthood
Demographic characteristics, socio-economic status (SES),
smoking habits and alcohol intake were derived from vali-
dated questionnaires. The AMAI scale (Asociacion Mexicana
de Agencias de Investigacion de Mercado) was used as an
indicator of SES. For the analysis, we collapsed the six cate-
gories to two (very low/low and medium/high), as the sam-
ple has low variability in SES.33 We obtained information
about alcohol intake from the National Addiction Survey
and classified the individuals according to their habitual
intake (daily-weekly, monthly, annually, never).34 We used
the same survey to gather information on smoking habits
and classified individuals as non-smokers, past-smokers
and active smokers. We also administered a food frequency
questionnaire,35 which was used to derive total energy
intake.
Statistical analysis
We compared the participant’s background characteristics,
as well as their mother’s BMI before pregnancy (self-re-
ported) and at delivery with respect to NAFLD status (yes
versus no), using the appropriate statistical tests based on
the distribution of the variables—i.e. two sample t-test or
median (interquaertile range [IQR]) and Kolmogorov–
Smirnov test for continuous variables and Fisher’s Exact
test for categorical variables. These associations informed
selection of covariates for multivariable models.
We then explored the independent associations of
maternal OWOB before and at the end of pregnancy,
and of participant’s OWOB at different life stages (child-
hood, adolescence and young adulthood), with ln-trans-
formed liver fat content in adulthood using linear
regression models and with the diagnosis of NAFLD
using logistic regression models. All models were adjusted
for mother’s age and education, socio-economic level of
the family, and participant’s sex, smoking, alcohol and
energy intake.
The generalised structural equation model (GSEM) is an
extension of generalised linear models that allowed us to
model direct and mediated effects that are expressed in a
multiple equation system where outcome variables could be
of any type (continuous or categorical variables).36 We
used a GSEM to assess the cumulative effects of maternal
OWOB and offspring OWOB during early life on NAFLD
risk. Our hypothesis was that maternal pre-pregnancy
OWOB increases the possibility of excess gestational weight
gain and thus maternal OWOB at the end of pregnancy.
Maternal obesity, in turn, increases risk of OWOB in the
offspring across the life course. Given that obesity is a key
risk factor of NAFLD, the inter-generational nature of
excess adiposity will likely be related to a higher percentage
of liver fat and NAFLD (Figure 1).
The specification of paths, and the selection of the vari-
ables that were included, are based on an a priori concep-
tual framework. The root mean square error of
approximation (RMSEA) was used to evaluate the good-
ness-of-fit, where a value <0.9 was considered acceptable.
In this analysis, we assessed ln-transformed liver fat content
as a continuous outcome via linear regression. The estimate
of interests was exponentiated beta estimates and 95% con-
fidence intervals (CI) from the linear regression models,
and odds ratios (OR) and 95% CI from the logistic regres-
sion models (OWOB).
Finally, to assess the possibility of selection bias, we
compared delivery characteristics of participants (mother,
i.e. age, schooling; offspring, i.e. birthweight, length)
included in the analytical sample versus the original cohort.
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All the analyses were performed in STATA 15 statistical
software (StataCorp LLC, College Station, TX, USA).
Results
The main characteristics of the participants are described
in Table 1. About half of the participants were male
(55%). At delivery they presented a mean weight of
3093 g (7.2% presented low birthweight) and a mean
gestational age of 39 weeks. Twenty-eight percent of the
participants started their pregnancy overweight/obese
(BMI >25 kg/m2); at delivery, 59% were overweight/
obese.
Median liver fat content was 1.4% (IQR 2.9), and
17% (n = 17) of participants had NAFLD. Participants
with NAFLD had mothers who were more likely to be
OWOB at delivery (83% versus 55%, P = 0.03) and were
themselves more likely to have been OWOB during ado-
lescence (59% versus 19%, P = 0.01) and young adult-
hood (94% versus 31%, P < 0.01) in comparison with
their healthy counterparts. When comparing the analyti-
cal sample with the original cohort, we found no differ-
ences on the variables evaluated except mother’s
education (almost 1 year more in the analytical sample,
Table S1), so we used this variable in the adjusting of
the models.
At the young-adult visit, the average age was 21.4 years
(0.5); 51% were classified as being at very low/low socio-
economic status and 44% were active smokers. Forty-eight
percent reported that they consumed alcohol once per year
or not at all, and 20% consumed alcohol on a weekly/daily
basis, no difference was found on alcohol intake between
those with and without NAFLD. None of the participants
reported consumption of more than 20 g of alcohol per
day (more than 2 and 3 servings per day men and women,
respectively).
Table 2 shows the association of OWOB variables at dif-
ferent stages with ln-transformed liver fat content as well
as with odds of NAFLD. Participants whose mothers were
OWOB (≥25 kg/m2) at delivery had a greater possibility
(OR = 4.16, P = 0.05) of having NAFLD. The relationship
of being OWOB strengthened with a later life stages (at the
MRS time).
GSEM results are shown in Table 3. Maternal pre-preg-
nancy OWOB almost doubled the likelihood of maternal
OWOB at delivery (O, 1.79; 95% CI 1.51–2.14). The subse-
quent possibility of an offspring with mothers who pre-
sented OWOB at delivery being OWOB during childhood
(before 4 years of age) was six times that of participants
born to women in the normal weight BMI category at
delivery (OR 6.02, 95% CI 1.12–32.30). Moreover, the same
participants who were OWOB before 4 years of age had
Figure 1. Generalised structural equation model of maternal and child overweight/obesity and its association with liver fat content (only statistically
significant coefficients/odds ratio are presented in the figure, for more details, please see Table 3).
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almost seven times greater odds of being OWOB during
adolescence (OR 6.83, 95% CI 1.12–24.24), compared with
those classified as normal weight by 4 years of age. Finally,
being OWOB versus normal weight during adolescence was
a strong determinant of staying OWOB in adulthood (OR
23.82, 95% CI 6.06–93.53).
Table 1. Characteristics of the analytical sample comparing pregnancy, childhood, adolescence and young adulthood related to the presence of
offspring NAFLD
All non-NAFLD NAFLD P




Normal (%) 58 (67.44) 47 (66.20) 11 (73.33) 0.76
Overweight/obesity (%) 28 (32.56) 24 (33.8) 4 (26.67)
BMI classification at delivery
Normal (%) 39 (39.80) 36 (45.00) 3 (16.67) 0.03
Overweight/obesity (%) 59 (60.20) 44 (55.00) 15 (83.33)
Offspring, at birth
Birth weight (g)* 3093 (398.10) 3075 (416.08) 3178 (394.79) 0.3
Low birth weight (<2500 g) (%) 7.2 8.7 0.0 0.2
Gestational age (weeks)* 39.4 (1.3) 39.1 (1.4) 39.4 (1.1) 0.3
Sex (% male) 53 (54.64) 44 (55.00) 9 (52.94) 0.5
Infant
Breastfeeding
Total (months)** 8.35 (7.89) 8.53 (8.06) 7.47 (7.18 1) 0.9
Never breastfed (%) 21 (21.65) 18 (22.5) 3 (17.65) 0.5
Breastfed (%) 76 (78.350) 62 (77.50) 14 (82.35)
Offspring, childhood
Being overweight/obese before 4 years of age
No (%) 82 (84.54) 70 (87.5) 12 (70.59) 0.08
Yes (%) 15 (16.16) 10 (12.50) 5 (29.41)
Offspring, adolescence
Being overweight/obese
No (%) 72 (74.23) 65 (81.25) 7 (41.18) 0.01
Yes (%) 25 (25.77) 15 (18.75) 10(58.82)
Offspring, young adulthood (at the time of MRS)
Age (years)* 21.4 (0.5) 21.4 (0.5) 21.4 (0.5) 0.9
Being overweight/obese
No (%) 56 (57.73) 55 (68.75) 1 (5.88) <0.01
Yes (%) 41 (42.27) 25 (31.25) 16 (94.12)
Smoking
Never 14 (14.43) 14 (17.5) 0 (0) 0.1
Past smoker 40 (41.24) 33 (41.25) 7 (41.18)
Active smoker 43 (44.33) 33 (41.25) 10 (58.82)
Alcohol intake
Never/annually 47 (48.45) 38 (47.5) 9 (52.94) 0.2
Monthly 30 (30.93) 23 (28.75) 7 (41.18)
Weekly/daily 20 (20.62) 19 (23.75) 1 (5.88)
Socioeconomic status
Very low/low 49 (50.52) 11 (64.71) 38 (47.50) 0.3
Medium/high 48 (49.48) 6 (35.29) 42 (52.50)
Energy intake (kcal/day)** 2811.2 (1956–3670) 2814.3 (2029– 3927) 2443.9 (1887–3358) 0.8
Maternal BMI classification: normal (<25 kg/m2), overweight (≥25 kg/m2); childhood overweight >2SD of the WHZ-score (WHO 2006);
adolescence and adult overweight/obese (≥25 kg/m2). Fisher Exact test for categorical variables.
*Mean (SD), two-sample t-test.
**Median (IQR), Kolmogorov–Simonov test.
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Finally, we found that OWOB in both the mothers as
well as the participants themselves was directly associated
with higher liver fat content. Participants whose mothers
were OWOB at delivery presented a higher average liver fat
content, compared with those whose mothers were classi-
fied as normal BMI (exp[b] 1.97, 95% CI 1.28–3.05).
OWOB in adulthood was also cross-sectionally associated




To our knowledge, this is the first study in a Mexican popu-
lation of young adults to investigate life course associations
of exposure to maternal and offspring OWOB from the in
utero period onward with offspring liver fat content in
young adulthood. Our estimations through the GSEM docu-
mented the influence of maternal OWOB on offspring
OWOB, as well as the influence of childhood OWOB in
adolescence and finally in young adulthood, which is consis-
tent with previous findings from other cohort studies.37–40
We found that 17% of the participants presented with
the more than 5% of liver fat fraction considered to be
NAFLD,29 which is consistent with what has been reported
for this age range.8,41 We identified OWOB as a determi-
nant (directly and indirectly) related to the development of
NAFLD among offspring in adulthood. This finding is
highly relevant in a country such as Mexico where more
Table 3. Association’s coefficients estimated from a generalised
structural equation model of OWOB at different time periods and
liver fat content










Mother’s age 1.02 (1.01–1.03)












Mother’s age 0.92 (1.00–1.03)
Overweight/obesity at adolescence
Overweight/obesity








Mother’s age 1.08 (0.98–1.19)










Mother’s age 1.03 (0.92–1.11)















Past smoker 1.30 (0.69–2.46)
Active smoker 1.89* (1.01–3.69)
Socio-economic status Very low/low Ref.
Medium/high 1.26 (0.82–1.95)




Mother’s age 1.00 (0.99–1.05)
*P < 0.05.
Table 2. Association between OWOB at different stages and liver




b P OR P
Maternal pre-pregnancy
overweight/obesity
0.15 0.61 0.49 0.32
Maternal overweight/obesity at
delivery
0.72 <0.01 4.16 0.05
Childhood overweight/obesity 0.23 0.51 2.70 0.19
Adolescence overweight/obesity 1.02 <0.01 6.03 <0.01
Young adulthood overweight/
obesity
1.29 <0.01 33.68 <0.01
Models adjusted by mother’s age and education, sex, socio-
economic level, smoking alcohol and energy intake. Maternal
overweight (≥25 kg/m2); childhood overweight >2SD of the WHZ-
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than 70% of women at reproductive age present with over-
weight or obesity;20 furthermore, around 30% of women
are expected to start pregnancy with a BMI >30 kg/m2.42
Our findings align with previous cross-sectional and
cohort studies that had demonstrated the association of
maternal obesity and NAFLD with larger samples.16,43-45
Previous studies have shown that maternal BMI is directly
correlated with neonatal intrahepatocellular lipid con-
tent,44,46 a phenomenon that can be attributed to the fact
that obese mothers, as compared with normal weight
women, mobilise increased nutrient (glucose and fatty
acids) availability to the fetus.47 This may present a chal-
lenge for the fetus in early pregnancy (first trimester), as
excess nutrients are not stored in the form of subcutaneous
fat until the third trimester.48 Instead, excess fuels made
available to the fetus result in fat accumulation in fetal
hepatocytes.49
We also found a strong positive and direct association
between the participants’ current BMI status and liver fat
content. These findings align with those of a systematic
review50 and a recent cohort study which detected three
times greater odds of NAFLD in midlife among those with
high BMI during adolescence51 and with other reports that
showed an increase in the severity of hepatic steatosis in
adolescents with higher BMI.52 The mentioned associations
were independent of the lifestyle covariates such as smok-
ing, energy and alcohol intake.
It is also important to note that we did not find a differ-
ence by sex in liver fat content, which is surprising given a
study in adolescents53 and several population-based studies
reporting higher NAFLD prevalence among men than
women.54-57 However, our finding is consistent with a pre-
vious study that found equal amounts of liver fat in adult
men and women.58
Strengths and limitations
There are some limitations to the present study. First, there
was a possible selection bias, as the participants were
selected as a convenience sample from the overall ELE-
MENT cohort; however, the only statistically different vari-
able was mother’s education and was not associated to the
outcome. Second, the self-report of pre-pregnancy weight
may have underestimated the role of pre-pregnancy BMI
on overweight at delivery. However, previous studies that
have used the same approach have shown that this self-re-
ported variable can be useful for screening and for discern-
ing associations with health outcomes.59,60 Lastly, the small
sample size in this analysis did not allow us to run a logis-
tic model using NAFLD as the outcome. The power esti-
mation for a sample of 97 required a minimum prevalence
of 30% and the observed prevalence in this sample was
17% (as expected for this age group). Nevertheless, we were
able to detect associations with the continuous variable
(liver fat content).
One strength of this study is the rich data on historical
exposure variables, which allowed us to assess the influ-
ence of pregnancy, childhood and adolescent weight status
on liver fat content in early adulthood. Our method of
liver fat assessment (1H MRS to measure the liver fat
fraction) has been previously validated and is currently
the best non-invasive method to quantify fat within the
liver.26
Interpretation
Dietary and lifestyle modifications, like weight control, are
currently the main method for treatment of NAFLD, espe-
cially in youth.61 The determinants of liver fat content that
we identified in this study point towards potential avenues
for early interventions. The strong association of maternal
overweight with offspring liver fat fraction during early
adulthood points to the possible beneficial effect on off-
spring metabolic health of achieving a healthy weight and
weight gain during pregnancy. The pregnancy period con-
stitutes a window of opportunity for prevention of non-
communicable diseases, as most pregnant women attend
antenatal care and are in contact with the healthcare system
(in Mexico 98.4% of pregnant women attend antenatal
care) during their pregnancy.62 It is also a unique opportu-
nity to identify women at high risk and make lifestyle
changes, as women are often highly motivated, especially
when they perceive associated benefits to their off-
spring.63,64
Finally, public health actions that promote weight con-
trol throughout life need to be reinforced as a way to pre-
vent complications related to obesity, such as NAFLD.
Conclusion
We found that maternal OWOB status is related to fatty
liver content in the offspring as young adults, even after
taking into account OWOB status and lifestyle factors in
the offspring. Encouraging overweight women to make life-
style changes before pregnancy that result in adequate
weight control could subsequently prevent chronic diseases
in the offspring.
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